Fundamentals Checklist
Created with Highcharts 10.1.03
Liabilities-1.84% (QoQ), -39.22% (YoY)
Cash Value+120.65% (QoQ), +935.46% (YoY)
Net Receivables+88.71% (QoQ), -98.36% (YoY)
Created with Highcharts 10.1.02
Earnings per Share-106.34% (QoQ), +55.17% (YoY)
Assets-11.3% (QoQ), +296.49% (YoY)
Created with Highcharts 10.1.01
Net Income-108.63% (QoQ), +7.14% (YoY)
MEDS - Revenue & Net Income
Created with Highcharts 10.1.0Drag the mouse to select multiple data points and show the change between themRevenueNet Income2019 Q42020 Q12020 Q22020 Q32020 Q42021 Q12021 Q22021 Q32021 Q42022 Q12022 Q22022 Q32022 Q42023 Q12023 Q22023 Q32023 Q42024 Q12024 Q2$-20M$-10M$0$10M$20M$30Munusualwhales.com
MEDS - Earnings per share
Created with Highcharts 10.1.0Drag the mouse to select multiple data points and show the change between themEarnings per Share2019 Q42020 Q12020 Q22020 Q32020 Q42021 Q12021 Q22021 Q32021 Q42022 Q12022 Q22022 Q32022 Q42023 Q12023 Q22023 Q32023 Q42024 Q12024 Q2$-20$-10$0$10$20$30unusualwhales.com
MEDS - EPS Impact by Buyback/Dilution
Subscribe to unlock
MEDS - Net Receivables
Subscribe to unlock
MEDS - Assets vs Liabilities
Subscribe to unlock
MEDS - Cash at Carrying Value
Subscribe to unlock
MEDS - Shares OutstandingSince 2019 Q4 shares have increased by 959.7K (192%) and by 52.31K (4%) since the start of 2024
Subscribe to unlock
MEDS - Shares Repurchased vs RSU granted
Subscribe to unlock